CD19 directed CAR T cell therapy in diffuse large B-cell lymphoma
CD19 directed CAR T cell therapy in diffuse large B-cell lymphoma |
https://doi.org/10.18632/oncotarget.25688
Alfonso Quintás-Cardama
|
29843-29844 |
Anchorage-dependent multicellular aggregate formation induces a quiescent stem-like intractable phenotype in pancreatic cancer cells
Anchorage-dependent multicellular aggregate formation induces a quiescent stem-like intractable phenotype in pancreatic cancer cells |
https://doi.org/10.18632/oncotarget.25732
Yukiko Miyatake,
Yusuke Ohta,
Shunji Ikeshita,
and Masanori Kasahara
|
29845-29856 |
Screening of microRNAs for a repressor of hepatitis B virus replication
Screening of microRNAs for a repressor of hepatitis B virus replication |
https://doi.org/10.18632/oncotarget.25557
Yutaka Naito,
Susumu Hamada-Tsutsumi,
Yusuke Yamamoto,
Akiko Kogure,
Yusuke Yoshioka,
Koichi Watashi,
Takahiro Ochiya,
and Yasuhito Tanaka
|
29857-29868 |
Effect of TP53 contact and conformational mutations on cell survival and erythropoiesis of human hematopoietic stem cells in a long term culture model
Effect of TP53 contact and conformational mutations on cell survival and erythropoiesis of human hematopoietic stem cells in a long term culture model |
https://doi.org/10.18632/oncotarget.25581
Azam Salari,
Kathrin Thomay,
Jana Lentes,
Juliane Ebersold,
Maike Hagedorn,
Britta Skawran,
Claudia Davenport,
Axel Schambach,
Brigitte Schlegelberger,
and Gudrun Göhring
|
29869-29876 |
Heuristic value-based framework for lung cancer decision-making
Heuristic value-based framework for lung cancer decision-making |
https://doi.org/10.18632/oncotarget.25643
Isa Mambetsariev,
Rebecca Pharaon,
Arin Nam,
Kevin Knopf,
Benjamin Djulbegovic,
Victoria M. Villaflor,
Everett E. Vokes,
and Ravi Salgia
|
29877-29891 |
The regulatory interplay between Oct-1 isoforms contributes to hematopoiesis and the isoforms imbalance correlates with a malignant transformation of B cells
The regulatory interplay between Oct-1 isoforms contributes to hematopoiesis and the isoforms imbalance correlates with a malignant transformation of B cells |
https://doi.org/10.18632/oncotarget.25648
Elizaveta V. Pankratova,
Alexander G. Stepchenko,
Irina D. Krylova,
Tatiana N. Portseva,
and Sofia G. Georgieva
|
29892-29905 |
A mechanism-based computational model to capture the interconnections among epithelial-mesenchymal transition, cancer stem cells and Notch-Jagged signaling
A mechanism-based computational model to capture the interconnections among epithelial-mesenchymal transition, cancer stem cells and Notch-Jagged signaling |
https://doi.org/10.18632/oncotarget.25692
Federico Bocci,
Mohit Kumar Jolly,
Jason Thomas George,
Herbert Levine,
and José Nelson Onuchic
|
29906-29920 |
Angiogenic miRNAs, the angiopoietin axis and related TIE2-expressing monocytes affect outcomes in cholangiocarcinoma
Angiogenic miRNAs, the angiopoietin axis and related TIE2-expressing monocytes affect outcomes in cholangiocarcinoma |
https://doi.org/10.18632/oncotarget.25699
Georgi Atanasov,
Corinna Dietel,
Linda Feldbrügge,
Christian Benzing,
Felix Krenzien,
Andreas Brandl,
Shadi Katou,
Katrin Schierle,
Simon C. Robson,
Katrin Splith,
Georg Wiltberger,
Anja Reutzel-Selke,
Sven Jonas,
Andreas Pascher,
Marcus Bahra,
Johann Pratschke,
and Moritz Schmelzle
|
29921-29933 |
The inhibition of malignant melanoma cell invasion of bone by the TLR7 agonist R848 is dependent upon pro-inflammatory cytokines produced by bone marrow macrophages
The inhibition of malignant melanoma cell invasion of bone by the TLR7 agonist R848 is dependent upon pro-inflammatory cytokines produced by bone marrow macrophages |
https://doi.org/10.18632/oncotarget.25711
Yoko Manome,
Dai Suzuki,
Ayako Mochizuki,
Emi Saito,
Kiyohito Sasa,
Kentaro Yoshimura,
Tomio Inoue,
Masamichi Takami,
Katsunori Inagaki,
Takahiro Funatsu,
and Ryutaro Kamijo
|
29934-29943 |
Tolerability of obinutuzumab therapy in patients with rituximab-relapsed/refractory B-cell malignancies - a retrospective single center cohort study
Tolerability of obinutuzumab therapy in patients with rituximab-relapsed/refractory B-cell malignancies - a retrospective single center cohort study |
https://doi.org/10.18632/oncotarget.25714
Theo Pirich,
Elisabeth Zwickl-Traxler,
Martin Pecherstorfer,
and Josef Singer
|
29944-29956 |
Aquaporin 1 suppresses apoptosis and affects prognosis in esophageal squamous cell carcinoma
Aquaporin 1 suppresses apoptosis and affects prognosis in esophageal squamous cell carcinoma |
https://doi.org/10.18632/oncotarget.25722
Yuzo Yamazato,
Atsushi Shiozaki,
Daisuke Ichikawa,
Toshiyuki Kosuga,
Katsutoshi Shoda,
Tomohiro Arita,
Hirotaka Konishi,
Shuhei Komatsu,
Takeshi Kubota,
Hitoshi Fujiwara,
Kazuma Okamoto,
Mitsuo Kishimoto,
Eiichi Konishi,
Yoshinori Marunaka,
and Eigo Otsuji
|
29957-29974 |
Loss of KIBRA function activates EGFR signaling by inducing AREG
Loss of KIBRA function activates EGFR signaling by inducing AREG |
https://doi.org/10.18632/oncotarget.25724
Ashley L. Mussell,
Kayla E. Denson,
He Shen,
Yanmin Chen,
Nuo Yang,
Costa Frangou,
and Jianmin Zhang
|
29975-29984 |
Combined external beam radiotherapy with carbon ions and tumor targeting endoradiotherapy
Combined external beam radiotherapy with carbon ions and tumor targeting endoradiotherapy |
https://doi.org/10.18632/oncotarget.25695
Claudius Melzig,
Azadeh Fahim Golestaneh,
Walter Mier,
Christian Schwager,
Samayita Das,
Julian Schlegel,
Felix Lasitschka,
Hans-Ulrich Kauczor,
Jürgen Debus,
Uwe Haberkorn,
and Amir Abdollahi
|
29985-30004 |
Deciphering splenic marginal zone lymphoma pathogenesis: the proposed role of microRNA
Deciphering splenic marginal zone lymphoma pathogenesis: the proposed role of microRNA |
https://doi.org/10.18632/oncotarget.25487
Jacob E. Robinson,
and Christine E. Cutucache
|
30005-30022 |
Correction: A phase II trial of 1st-line modified-FOLFOXIRI plus bevacizumab treatment for metastatic colorectal cancer harboring RAS mutation: JACCRO CC-11
Correction: A phase II trial of 1st-line modified-FOLFOXIRI plus bevacizumab treatment for metastatic colorectal cancer harboring RAS mutation: JACCRO CC-11 |
https://doi.org/10.18632/oncotarget.25775
Hironaga Satake,
Yu Sunakawa,
Yuji Miyamoto,
Masato Nakamura,
Hiroshi Nakayama,
Manabu Shiozawa,
Akitaka Makiyama,
Kazuma Kobayashi,
Yutaro Kubota,
Misuzu Mori,
Masahito Kotaka,
Akinori Takagane,
Masahiro Gotoh,
Masahiro Takeuchi,
Masashi Fujii,
Wataru Ichikawa,
and Takashi Sekikawa
|
30023-30023 |
Correction: MYCN acts as a direct co-regulator of p53 in MYCN amplified neuroblastoma
Correction: MYCN acts as a direct co-regulator of p53 in MYCN amplified neuroblastoma |
https://doi.org/10.18632/oncotarget.25776
Saurabh Agarwal,
Giorgio Milazzo,
Kimal Rajapakshe,
Ronald Bernardi,
Zaowen Chen,
Barbieri Eveline,
Jan Koster,
Giovanni Perini,
Cristian Coarfa,
and Jason M. Shohet
|
30024-30024 |